A sensing system developed at Cambridge is being commercialised in the UK for use in rapid, low-cost DNA sequencing, which would make the prediction and diagnosis of disease more efficient, and individualised treatment more affordable…. A sensing system developed at Cambridge is being commercialised in the UK for use in rapid, low-cost DNA sequencing, which would make the prediction and diagnosis of disease more efficient, and individualised treatment more affordable.
Read more http://www.nano.org.uk/news/1878/